Also, B lymphocyte stimulator (BLyS), a pivotal factor for B cell activation and survival, was significantly upregulated in lesional skin (68), supporting enhanced B cell activation in the context of cutaneous lupus pathologies. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.